Literature DB >> 17156114

Perioperative and intraoperative pain and anesthetic care of the chronic pain and cancer pain patient receiving chronic opioid therapy.

Dima Rozen1, Gerald W Grass.   

Abstract

The expanding role of the anesthesiologist as a "perioperative physician" places ever-increasing demands upon his or her clinical skills and knowledge. One area of growing concern for the anesthesiologist involves the perioperative assessment and management of the opioid-tolerant chronic pain patient. Opioids occupy a position of unsurpassed clinical utility for the treatment of many types of painful conditions. Coupled with noticeable shifts in physician attitudes that have occurred in recent years regarding the use of opioids for the treatment of benign and malignancy-related pain, many more patients are presenting for surgical procedures who are opioid tolerant. It is important therefore that the practicing anesthesiologist become familiar with the currently available opioid formulations, including drug interactions and side effects, in order to better plan the patient's perioperative anesthetic needs and management. Unfortunately, there is a lack of scientifically rigorous studies in this important area, and most of the information must be derived from anecdotal reports and personal experience of anesthesiologists working in this field. In this review, we shall discuss some aspects of current chronic pain management, the newer forms of opioid administration which may be unfamiliar to the anesthesiologist, as well as clinical aspects of opioid use and tolerance including the impact it may have on perioperative anesthetic management.

Entities:  

Year:  2005        PMID: 17156114     DOI: 10.1111/j.1533-2500.2005.05104.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  2 in total

1.  Perioperative management of patients with cancer pain treated with opioids: a retrospective study.

Authors:  Takako Fujita; Motoyo Iwade; Keiko Hamada; Makoto Ozaki
Journal:  J Anesth       Date:  2018-06-06       Impact factor: 2.078

2.  GC-MS Analysis and Various In Vitro and In Vivo Pharmacological Potential of Habenaria plantaginea Lindl.

Authors:  Mater H Mahnashi; Yahya S Alqahtani; Bandar A Alyami; Ali O Alqarni; Mohammad Ahmed Alshrahili; Mahrous A Abou-Salim; Mohammed N Alqahtani; Sadaf Mushtaq; Abdul Sadiq; Muhammad Saeed Jan
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.